Site Search
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Classical Hematology Conference - Insights
This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.
Myasthenia Gravis: The Role of Apheresis - Insights
In this month’s episode of Lab Medicine Rounds, Justin Kreuter, M.D., interviews Jeffrey Winters, M.D., the medical director of the Therapeutic Apheresis Treatment Unit at Mayo Clinic for Myasthenia Gravis Awareness Month.
Reversing a dire disorder: Lorinda McKinley - Insights
Advanced testing at Mayo Clinic Laboratories that confirmed a diagnosis of myasthenia gravis put Lorinda McKinley on the road to renewed health after she nearly lost it all to the rare autoimmune disease.
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
Ganglioside-associated neuropathies - Insights
Learn how Mayo Clinic Laboratories’ ganglioside antibody evaluation can provide diagnostic clarity and a path forward for patients impacted by autoimmune peripheral neuropathy.
Comprehensive inherited neuropathy panel - Insights
Learn how our comprehensive inherited neuropathy panel simplifies the diagnostic process by evaluating 186 genes with associations to inherited neuropathy.
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
Autoimmune neurology evolution - Insights
Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.
Beyond the Test Result: Greg Widseth - Insights
Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that...
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Back from the brink: Sheila Lewis - Insights
Mayo Clinic Laboratories’ comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from autoimmune encephalitis.
Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.
Autoimmune Encephalitis Misdiagnosis - Insights
In this month's "Hot Topic," Eoin Flanagan, M.B., B. Ch., discusses the important issue of autoimmune encephalitis misdiagnosis and identifies red flags that be useful in clinical practice to suggest alternative diagnoses and highlight...
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.
Glimmer of Hope: Gregor Heinrich - Insights
While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the...
Kelch-11 Autoantibody Test [Test in Focus] - Insights
Divyanshu (Div) Dubey, M.B.B.S., explains how Mayo Clinic Labs’ new Kelch-11 antibody test — the first in the world — can confirm diagnosis, guide treatment, and improve outcomes in patients affected by testicular cancer-associated...
Novel biomarkers added to movement disorders profile - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
Paraneoplastic Vision Loss Evaluation [Test in Focus] - Insights
Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when...
Autoimmune Myelopathy Evaluation [Test in Focus] - Insights
Patients with autoimmune myelopathy present with subacute onset and rapid progression of spinal cord symptoms (weakness, gait difficulties, loss of sensation, neuropathic pain, and bowel and bladder dysfunction). Autoimmune myelopathy...
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
Mucopolysaccharidosis - Insights
Learn more about how Mayo Clinic Laboratories’ testing for mucopolysaccharidosis can assist with diagnosis and disease management.
Learn more about how Mayo Clinic Laboratories’ unique testing for sphingolipidoses, including Gaucher and Krabbe diseases, can confirm diagnosis and guide disease management.
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Congenital disorders of glycosylation - Insights
In this month’s “Hot Topic,” Gessi Pino, a genetic counselor in the Biochemical Genetics Lab at Mayo Clinic, and Kimiyo Raymond, M.D., a clinical consultant in the laboratory and an expert in Congenital Disorders of Glycosylation (CDG),...
Organic acid disorders - Insights
Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.
Amino acid disorders - Insights
Learn more about how amino acid metabolism testing at Mayo Clinic Laboratories can assist in diagnosing the most preventable and treatable amino acid disorders.
Dr. Leslie Donato discusses lipid testing on ADLM's Laborastories: The Podcast - Insights
Dr. Leslie Donato recently joined “Laborastories: The Podcast,” hosted by the Association for Diagnostics & Laboratory Medicine (ADLM) president Dr. Anthony Killeen, to discuss the publication of the new ADLM lipid and lipoprotein testing...
Establishing a trusted lab partner in an evolving landscape - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...
Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.
Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Vanda Lennon, M.D., Ph.D., founder of the Neuroimmunology Laboratory and now...
Autoimmune Encephalitis Diagnosis and Misdiagnosis - Insights
PACEIn this month’s “Virtual Lecture” Eoin Flanagan, M.D., B.Ch., reviews how to diagnose autoimmune encephalitis, what to watch that may suggest a different diagnosis, discuss neural autoantibodies interpretation and putting test results...
Visit Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024 - Insights
Join Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024.
Neurofilament Light Chain (NFLC) - Insights
Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...
Optic Neuritis in the Era of Biomarkers - Insights
Antibodies to aquaporin-4 and myelin oligodendrocyte glycoprotein (MOG) are recently described biomarkers seen in a subset of atypical optic neuritis which have revolutionized our understanding of the condition. In this “Hot Topic,” my...
Study Shows Drug Reduces Risk of Relapse with Neuromyelitis Optica - Insights
"This study offers hope to patients, since each attack in NMO can cause loss of visual or motor function," says Sean Pittock, M.D., a Mayo Clinic neurologist and first author.